Skip to main content
. 2016 Nov 11;41(22):1709–1717. doi: 10.1097/BRS.0000000000001707

TABLE 3.

Categorical Distribution of Patient's Global Impression of Improvement Results at the Final Evaluation

Category Placebo n = 226 Duloxetine n = 230 P
Improved* 163 (72.1) 191 (83.0) 0.0067
Unchanged 59 (26.1) 34 (14.8)
Worsened 4 (1.8) 5 (2.2)

Data are presented as n (%).

*The “Improved” category included patients who responded “Very much improved”, “Much improved”, or “Minimally improved”.

The “Worsened” category included patients who responded “Very much worse”, “Much worse”, or “Worse”.